These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 28280852)

  • 1. TANTIGEN: a comprehensive database of tumor T cell antigens.
    Olsen LR; Tongchusak S; Lin H; Reinherz EL; Brusic V; Zhang GL
    Cancer Immunol Immunother; 2017 Jun; 66(6):731-735. PubMed ID: 28280852
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TANTIGEN 2.0: a knowledge base of tumor T cell antigens and epitopes.
    Zhang G; Chitkushev L; Olsen LR; Keskin DB; Brusic V
    BMC Bioinformatics; 2021 Apr; 22(Suppl 8):40. PubMed ID: 33849445
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NEPdb: A Database of T-Cell Experimentally-Validated Neoantigens and Pan-Cancer Predicted Neoepitopes for Cancer Immunotherapy.
    Xia J; Bai P; Fan W; Li Q; Li Y; Wang D; Yin L; Zhou Y
    Front Immunol; 2021; 12():644637. PubMed ID: 33927717
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Isolation of T cell receptors targeting recurrent neoantigens in hematological malignancies.
    Tubb VM; Schrikkema DS; Croft NP; Purcell AW; Linnemann C; Freriks MR; Chen F; Long HM; Lee SP; Bendle GM
    J Immunother Cancer; 2018 Jul; 6(1):70. PubMed ID: 30001747
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting Neoepitopes to Treat Solid Malignancies: Immunosurgery.
    de Sousa E; Lérias JR; Beltran A; Paraschoudi G; Condeço C; Kamiki J; António PA; Figueiredo N; Carvalho C; Castillo-Martin M; Wang Z; Ligeiro D; Rao M; Maeurer M
    Front Immunol; 2021; 12():592031. PubMed ID: 34335558
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HLA Ligand Atlas: a benign reference of HLA-presented peptides to improve T-cell-based cancer immunotherapy.
    Marcu A; Bichmann L; Kuchenbecker L; Kowalewski DJ; Freudenmann LK; Backert L; Mühlenbruch L; Szolek A; Lübke M; Wagner P; Engler T; Matovina S; Wang J; Hauri-Hohl M; Martin R; Kapolou K; Walz JS; Velz J; Moch H; Regli L; Silginer M; Weller M; Löffler MW; Erhard F; Schlosser A; Kohlbacher O; Stevanović S; Rammensee HG; Neidert MC
    J Immunother Cancer; 2021 Apr; 9(4):. PubMed ID: 33858848
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of a new HLA-A*0201-restricted cytotoxic T lymphocyte epitope from CML28.
    Han JF; Zhao TT; Liu HL; Lin ZH; Wang HM; Ruan ZH; Zou LY; Wu YZ
    Cancer Immunol Immunother; 2006 Dec; 55(12):1575-83. PubMed ID: 16534571
    [TBL] [Abstract][Full Text] [Related]  

  • 8. T Cell Epitope Prediction and Its Application to Immunotherapy.
    Schaap-Johansen AL; Vujović M; Borch A; Hadrup SR; Marcatili P
    Front Immunol; 2021; 12():712488. PubMed ID: 34603286
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HPVdb: a data mining system for knowledge discovery in human papillomavirus with applications in T cell immunology and vaccinology.
    Zhang GL; Riemer AB; Keskin DB; Chitkushev L; Reinherz EL; Brusic V
    Database (Oxford); 2014; 2014():bau031. PubMed ID: 24705205
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of promiscuous KIF20A long peptides bearing both CD4+ and CD8+ T-cell epitopes: KIF20A-specific CD4+ T-cell immunity in patients with malignant tumor.
    Tomita Y; Yuno A; Tsukamoto H; Senju S; Kuroda Y; Hirayama M; Irie A; Kawahara K; Yatsuda J; Hamada A; Jono H; Yoshida K; Tsunoda T; Kohrogi H; Yoshitake Y; Nakamura Y; Shinohara M; Nishimura Y
    Clin Cancer Res; 2013 Aug; 19(16):4508-20. PubMed ID: 23714729
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of neoepitope reactive T-cell receptors guided by HLA-A*03:01 and HLA-A*11:01 immunopeptidomics.
    Ade CM; Sporn MJ; Das S; Yu Z; Hanada KI; Qi YA; Maity T; Zhang X; Guha U; Andresson T; Yang JC
    J Immunother Cancer; 2023 Sep; 11(9):. PubMed ID: 37758652
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of noncanonical melanoma-associated T cell epitopes for cancer immunotherapy.
    Bredenbeck A; Losch FO; Sharav T; Eichler-Mertens M; Filter M; Givehchi A; Sterry W; Wrede P; Walden P
    J Immunol; 2005 Jun; 174(11):6716-24. PubMed ID: 15905511
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DeepHLApan: A Deep Learning Approach for Neoantigen Prediction Considering Both HLA-Peptide Binding and Immunogenicity.
    Wu J; Wang W; Zhang J; Zhou B; Zhao W; Su Z; Gu X; Wu J; Zhou Z; Chen S
    Front Immunol; 2019; 10():2559. PubMed ID: 31736974
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epitope distribution in ordered and disordered protein regions - part A. T-cell epitope frequency, affinity and hydropathy.
    Mitić NS; Pavlović MD; Jandrlić DR
    J Immunol Methods; 2014 Apr; 406():83-103. PubMed ID: 24614036
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Cancer Epitope Database and Analysis Resource: A Blueprint for the Establishment of a New Bioinformatics Resource for Use by the Cancer Immunology Community.
    Koşaloğlu-Yalçın Z; Blazeska N; Carter H; Nielsen M; Cohen E; Kufe D; Conejo-Garcia J; Robbins P; Schoenberger SP; Peters B; Sette A
    Front Immunol; 2021; 12():735609. PubMed ID: 34504503
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumor-specific shared antigenic peptides recognized by human T cells.
    Van Der Bruggen P; Zhang Y; Chaux P; Stroobant V; Panichelli C; Schultz ES; Chapiro J; Van Den Eynde BJ; Brasseur F; Boon T
    Immunol Rev; 2002 Oct; 188():51-64. PubMed ID: 12445281
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epitope distribution in ordered and disordered protein regions. Part B - Ordered regions and disordered binding sites are targets of T- and B-cell immunity.
    Pavlović MD; Jandrlić DR; Mitić NS
    J Immunol Methods; 2014 May; 407():90-107. PubMed ID: 24726865
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Discovery and Selection of Hepatitis B Virus-Derived T Cell Epitopes for Global Immunotherapy Based on Viral Indispensability, Conservation, and HLA-Binding Strength.
    de Beijer MTA; Jansen DTSL; Dou Y; van Esch WJE; Mok JY; Maas MJP; Brasser G; de Man RA; Woltman AM; Buschow SI
    J Virol; 2020 Mar; 94(7):. PubMed ID: 31852786
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of HLA-A*03, A*11 and B*07-restricted melanoma-associated peptides that are immunogenic in vivo by vaccine-induced immune response (VIIR) analysis.
    Reynolds SR; Celis E; Sette A; Oratz R; Shapiro RL; Johnston D; Fotino M; Bystryn JC
    J Immunol Methods; 2000 Oct; 244(1-2):59-67. PubMed ID: 11033019
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The neoepitope landscape of breast cancer: implications for immunotherapy.
    Narang P; Chen M; Sharma AA; Anderson KS; Wilson MA
    BMC Cancer; 2019 Mar; 19(1):200. PubMed ID: 30832597
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.